We use GLP-1 as a case study to show how belief and behaviour now spread. We connect the bauble effect, the tattoo effect, and the influencer economy into a practical framework for research design and communication planning in 2026.
GLP-1s have done something most medicines never do.
They’ve escaped the clinic and entered pop culture.
You can see it in two ‘odd’ little signals.
First, the ‘bauble’ effect. Like Christmas ornaments, once they’re up, you suddenly notice them everywhere. GLP-1 is now like that. You spot it in headlines, podcasts, conversations, even jokes. Attention turns into perceived prevalence. And on social platforms, algorithms don’t just reflect reality, they amplify whatever people can’t stop looking at.
Second, the tattoo effect. When someone tattoos ‘GLP-1’ on their body, that is not a rational health decision. It’s a social signal. It’s identity, pride, stigma, and belonging. It’s the medicine that becomes a story you can wear.
Now layer on the bigger shift. Healthcare is getting more consumer ish. Patients are not only asking, “is it true?’ They’re asking, ‘who do I trust?’ and increasingly that trust travels through people, not institutions. Influencers. Creators. Peers. Sometimes fake doctors. Sometimes celebrity endorsement scams. The incentives reward certainty and confidence, not careful accuracy.
or our clients their competitors aren’t only another pharma brands. Their competitor is uncertainty. And whoever sells certainty fastest will win attention.
For market researchers, this changes the job. Measuring recall and preference is no longer enough (was it ever?). We need to understand what makes something feel true, what makes it socially sayable, and what makes it stick in real life.
Not a lecture. It’s example-led, fast, and built around short audience interactions.
What you will walk away with…
- An updated understanding of how belief forms in healthcare in 2026
Why attention, repetition, and social proof can make things feel true, and how that changes what patients and even HCPs accept as ‘credible’. - Insights into why GLP-1 has become cultural, not just clinical
What the ‘bauble’ and tattoo signals reveal about identity, stigma, pride, and moral permission, and why those forces now shape uptake and persistence. - A clear view of what influencers are really doing to health decision-making
They’re not broadcasting info, but supplying certainty, belonging, and a trusted narrator, and why that often beats institutional expertise in the moment. - A sharper perspective on what this means for pharma brand roles and HCP-patient dynamics
How trust is shifting, what patients now expect from brands, and how clinicians increasingly act as interpreters of meaning, not just gatekeepers of evidence.
Speaker: Chris Loxley, Behavioural Scientist - RD - Adelphi
Convenor: Simon Fitall, CEO Tudor Health and LDC Member